UK Pharma Complaints Delay: Public Health at Risk?

Investigation reveals significant delays in processing complaints against UK drug companies, raising concerns about patient safety and public health. Increased fees and growing backlogs hinder the current self-regulatory system's effectiveness. Delays of up to 13 years highlight the need for stronger and timely resolution. The impact on public health and patient safety is a risk if unethical practices are not promptly addressed. A more efficient system is crucial for restoring public confidence and safeguarding patient safety.